Document:

Exhibit
      10.34

    ASYRMATOS,
      INC.

    

    CONTRIBUTION
      AGREEMENT

    

    This
      Contribution Agreement (the “Agreement”) is effective as of February 20, 2008
      (the “Effective Date”), by and among Asyrmatos, Inc., a Delaware corporation
      (the “Company”) and Lumera Corporation, a Delaware corporation (the
“Founder”).

     

    Recitals

    

    WHEREAS,
      Founder desires to transfer the business and the assets used in the development
      of high data-rate wireless transceiver systems, known as the millimeter wave
      communication system of the Founder (the “Business”) as set forth herein, in
      exchange for Class L Preferred Stock of the Company, par value $0.01 per share
      (the “Preferred Stock”), and the Company desires to sell such shares to Founder;
      and

     

    WHEREAS,
      the Founder and the Company shall enter into the Ancillary Agreements and the
      Company shall amend its Certificate of Incorporation, in order to effectuate
      the
      Contemplated Transactions.

     

    NOW
      THEREFORE, in consideration of the mutual covenants and agreements contained
      herein, the benefits to accrue to the parties hereto and other good and valuable
      consideration, the receipt of which is hereby acknowledged, the parties agree
      as
      follows:

     

    1. Issuance
      of Shares.
      The
      Company hereby agrees to issue and sell to the Founder, and the Founder agrees
      to acquire 1,000 shares (the “Shares”) of the Preferred Stock in exchange for
      the consideration described in the recitals above. 

     

    2. Transfer
      of Assets.
      The
      Founder hereby assigns, transfers, conveys and delivers to the Company all
      of
      its right, title and interest in and to all of the following and only the
      following assets (the “Transferred Assets”):

     

    (a) the
      Subject Intellectual Property listed on Schedule
      I,
      goodwill associated therewith and licenses and sublicenses granted in respect
      thereto and rights thereunder; and

     

    (b) all
      computer applications, programs and other software, whether in source or object
      code and including all related data and documentation, including, without
      limitation, operating software, network software, firmware, middleware, design
      software, design tools, systems documentation and instructions listed on
Schedule
      I.

     

    3. Nontransferability
      of Shares.
      The
      Shares acquired by the Founder pursuant to this Agreement shall not be sold,
      transferred, pledged, assigned or otherwise encumbered or disposed of except
      as
      provided below or in the Ancillary Agreements. Any purported transfer in
      contravention of any of the provisions of this Agreement or the Ancillary
      Agreements shall be null and void.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    4. Representations;
      Restrictive Legend.

     

    a. The
      Founder represents, warrants and covenants that: (i) the Shares are being
      acquired for the Founder’s account for investment only, and not with a view to,
      or for sale in connection with, any distribution of the Shares in violation
      of
      the federal Securities Act of 1933, as amended (the “1933 Act”), or any rule or
      regulation under the 1933 Act, (ii) the Founder has had such opportunity as
      the
      Founder has deemed adequate to obtain from representatives of the Company such
      information as is necessary to permit the Founder to evaluate the merits and
      risks of the Founder’s investment in the Company, (iii) the Founder is able to
      bear the economic risk of holding the Shares for an indefinite period, and
      (iv)
      the Founder understands that (A) the Shares will not be registered under the
      1933 Act; (B) the Shares cannot be sold, transferred or otherwise disposed
      of
      unless it is subsequently registered under the 1933 Act or an exemption from
      registration is then available; and (C) there is now no registration statement
      on file with the SEC with respect to any securities of the Company and the
      Company has no obligation or firm current plan to register the Shares under
      the
      1933 Act.

     

    b. The
      Founder represents and warrants that it is entitled to retain the Shares for
      its
      own account and that the Founder is not obligated (by contract, applicable
      law
      or otherwise) to (i) sell, transfer, pledge, assign, encumber or otherwise
      dispose of any Shares to, or (ii) share voting or dispositive power over any
      Shares with, any third party. 

     

    c. Any
      certificates representing the Shares shall have affixed thereto a legend
      substantially in the following form, in addition to any other legends required
      by applicable state law or by the by-laws of the Company, as in effect from
      time
      to time:

     

    “The
      shares of stock represented by this certificate have not been registered under
      the Securities Act of 1933, as amended, and may not be transferred, sold, or
      otherwise disposed of in the absence of an effective registration statement
      with
      respect to the shares evidenced by this certificate, filed and made effective
      under the Securities Act of 1933, or an opinion of counsel satisfactory to
      the
      Company to the effect that registration under such Act is not
      required.”

     

    5. Representations
      and Warranties of the Founder.

     

    The
      Founder makes the
      following representations and warranties
      to the Company:

     

    a. Due
      Organization.
      The
      Founder is a Delaware corporation, and is validly existing and in good standing
      under the laws of the jurisdiction of its organization. 

     

    b. Authorization. The
      execution, delivery and performance by the Founder of this Agreement and each
      Ancillary Agreement to which it is (or will be) a party and the consummation
      of
      the Contemplated Transactions are within the power and authority of the Founder
      and have been duly authorized by all necessary action on the part of the
      Founder. This Agreement and each Ancillary Agreement to which it is (or will
      be)
      a party (i) has been (or in the case of Ancillary Agreements to be entered
      into after the Effective Date, will be) duly executed and delivered by the
      Founder and (ii) is (or in the case of Ancillary Agreements to be entered
      into after the Closing, will be) a legal, valid and binding obligation of the
      Founder, enforceable against the Founder in accordance with its terms except
      as
      the enforceability thereof may be limited by bankruptcy, insolvency, moratorium
      or other laws affecting the enforcement of creditors’ rights or the availability
      of equitable remedies. 

     

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

     

    c. No
      Conflicts; Approvals. No
      action
      by (including any authorization, consent or approval), or in respect of, or
      filing with, any Governmental Authority is required for, or in connection with,
      the valid and lawful (i) authorization, execution, delivery and performance
      by
      the Founder of this Agreement and each Ancillary Agreement to which it is (or
      will be) a party or (ii) the consummation of the
      Contemplated Transactions by the Founder. No
      provision of any applicable Legal Requirement and no Government Order will
      prohibit the consummation of the Contemplated Transactions.

     

    d. Non-Contravention.
      Neither
      the execution, delivery or performance of this Agreement or any Ancillary
      Agreement to which it is (or will be) a party, nor the consummation by the
      Founder of the obligations contemplated hereby or thereby (i) will
      violate
      any Legal Requirement applicable to the Founder, (ii)
      result
      in the creation or imposition of an encumbrance upon, or the forfeiture of,
      any
      Transferred Asset, or (iii) result in a breach or violation of, or default
      under, the Organizational Documents of the Founder.

     

    6. Representations
      and Warranties of the Company.

     

    a. Due
      Organization.
      The
      Company is a Delaware corporation, and is validly existing and in good standing
      under the laws of the jurisdiction of its organization. 

     

    b. Authorization.
      The
      execution, delivery and performance by the Company of this Agreement and each
      Ancillary Agreement to which it is (or will be) a party and the consummation
      of
      the Contemplated Transactions are within the power and authority of the Company
      and have been duly authorized by all necessary action on the part of the
      Company. This Agreement and each Ancillary Agreement to which it is (or will
      be)
      a party (i) has been (or in the case of Ancillary Agreements to be entered
      into after the Effective Date, will be) duly executed and delivered by the
      Company and (ii) is (or in the case of Ancillary Agreements to be entered
      into after the Closing, will be) a legal, valid and binding obligation of the
      Company, enforceable against the Company in accordance with its terms except
      as
      the enforceability thereof may be limited by bankruptcy, insolvency, moratorium
      or other laws affecting the enforcement of creditors’ rights or the availability
      of equitable remedies. 

     

    c. No
      Conflicts; Approvals.
      No
      action by (including any authorization, consent or approval), or in respect
      of,
      or filing with, any Governmental Authority is required for, or in connection
      with, the valid and lawful (i) authorization, execution, delivery and
      performance by the Company of this Agreement and each Ancillary Agreement to
      which it is (or will be) a party or (ii) the consummation of the Contemplated
      Transactions by the Company. No provision of any applicable Legal Requirement
      and no Government Order will prohibit the consummation of the Contemplated
      Transactions.

     

    d. Non-Contravention.
      Neither
      the execution, delivery or performance of this Agreement or any Ancillary
      Agreement to which it is (or will be) a party, nor the consummation by the
      Company of the obligations contemplated hereby or thereby (i) will violate
      any
      Legal Requirement applicable to the Company, (ii) result in the creation or
      imposition of an encumbrance upon, or the forfeiture of, any Transferred Asset,
      or (iii) result in a breach or violation of, or default under, the
      Organizational Documents of the Company.

     

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

     

    7. Definitions.

     

    a. “Agreement”
has
      the
      meaning set forth in the introductory paragraph hereof.

     

    b. “Ancillary
      Agreements”
means
      the Investors’ Rights Agreement, Right of First Refusal and Co-Sale Agreement
      and Voting Agreement that the Founder and the Company are entering into in
      connection with the Contemplated Transactions and the Bill of Sale, Patent
      Assignment and Assignment and Assumption Agreement that are attached as exhibits
      hereto.

     

    c. “Applicable
      Law”
means,
      with respect to any party to this Agreement, all domestic or foreign federal,
      state or local statute, law, ordinance, rule, administrative interpretation,
      regulation, order, writ, injunction, directive, judgment, decree, policy,
      guideline or other Legal Requirement (whether legislatively, judicially, or
      administratively promulgated) applicable to such party or its Affiliates,
      properties, assets, officers, directors, employees or agents.

     

    d. “Business”
has
      the
      meaning set forth in the Recitals hereof.

     

    e. “Business
      Day” means
      any
      day that is not a Saturday, Sunday or other day on which banks are authorized
      to
      close in the State of Washington.

     

    f. “Contemplated
      Transactions” means,
      collectively, the transactions contemplated by this Agreement, including (a)
      the
      sale and purchase of the Transferred Assets; (b) the sale and purchase of the
      Shares, and (c) the execution, delivery and performance of the Ancillary
      Agreements.

     

    g. “Government
      Order” means
      any
      order, writ, judgment, injunction, decree, stipulation, ruling, determination
      or
      award entered by or with any Governmental Authority.

     

    h. “Governmental
      Authority”
means
      any United States federal, state or local or any foreign government, or
      political subdivision thereof, or any multinational organization or authority
      or
      any authority, agency or commission entitled to exercise any administrative,
      executive, judicial, legislative, police, regulatory or taxing authority or
      power, any court or tribunal (or any department, bureau or division thereof),
      or
      any arbitrator or arbitral body.

     

    i. “Intellectual
      Property” means
      all
      embodiments of, and the entire right, title and interest in and to all
      proprietary rights of every kind and nature in, including all rights and
      interests pertaining to or deriving from, any of: (a) patents and patent
      applications (whether foreign or domestic), inventions and innovations and
      all
      improvements thereto, patent disclosures, invention disclosures, copyrights,
      copyrightable works of expression, derivative works thereof, mask work rights,
      technology, know-how, processes, trade secrets, algorithms, inventions,
      innovations, information (including ideas, research and development, know-how,
      formulas, compositions, processes and techniques, data, designs, drawings,
      specifications, customer lists, supplier lists, licensor lists, pricing and
      cost
      information, business and marketing plans and proposals, documentation and
      manuals), works, proprietary data, databases, formulae and research and
      development data; (b) distinctive identifiers, corporate names, trademarks,
      trade names, service marks, service names, brands, trade dress and logos,
      together with all translations, adaptations, derivations and combinations
      thereof, and the goodwill and activities associated therewith and all
      improvements thereto; (c) all computer software (whether in source or object
      code and including all related data and documentation); (d) any and all
      registrations, applications, recordings, licenses, common-law rights and
      contracts relating to any of the foregoing; (e) all copies and tangible
      embodiments thereof, in any and all forms and mediums now known or hereinafter
      created; and (f) any and all legal actions and rights to sue at law or in equity
      for any past or future infringement or other impairment of any of the foregoing,
      including the right to receive all proceeds and damages therefrom, and all
      rights to obtain renewals, reissuances, revisions, reexaminations,
      continuations, divisions or other extensions of legal protections pertaining
      thereto, provided that the Intellectual Property shall not include assets
      described in Section 3 of this Agreement.

     

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

     

    j. “Legal
      Requirement” means
      any
      United States federal, state or local or foreign law, statute, standard,
      ordinance, code, rule, regulation, resolution or promulgation, or any Government
      Order, or any license, franchise, permit or similar right granted under any
      of
      the foregoing, or any similar provision having the force or effect of
      law.

     

    k. “Organizational
      Documents”
means,
      with respect to any Person (other than an individual), (a) the certificate
      or articles of incorporation or organization and any joint venture, limited
      liability company, operating or partnership agreement and other similar
      documents adopted or filed in connection with the creation, formation or
      organization of such Person and (b) all by-laws, limited liability company
      agreements, voting agreements and similar documents, instruments or agreements
      relating to the organization or governance of such Person, in each case, as
      amended or supplemented.

     

    l. “Person” means
      any
      individual or corporation, association, partnership, limited liability company,
      joint venture, joint stock or other company, business trust, trust,
      organization, Governmental Authority or other entity of any kind.

     

    m. “Subject
      Intellectual Property”
means
      all Intellectual Property owned or licensed by the Founder that is related
      to or
      arose from the Business, provided that the Subject Intellectual Property shall
      not include assets described in Section 3 of this Agreement. 

     

    8. Ancillary
      Agreements.
      Founder
      shall execute and deliver to the Company a Bill of Sale in substantially the
      form of Exhibit A (“Bill of Sale”), Patent Assignment in substantially the form
      of Exhibit B (“Patent Assignment”) and Assignment and Assumption Agreement in
      substantially the form of Exhibit C (“Assignment and Assumption Agreement”), and
      such other instruments of conveyance and assignment as are reasonably requested
      by the Company to vest in the Company title to the Transferred Assets.
      Additionally, the Founder and the Company shall enter into an Investors’ Rights
      Agreement, Right of First Refusal and Co-Sale Agreement and Voting Agreement
      and
      the Company shall cause its employees and shareholders, as requested by the
      Founder, to be parties to such agreements.

     

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

    

     

    9. Further
      Assurances.
      Each
      party hereto shall execute, deliver, file and record, or cause to be executed,
      delivered, filed and recorded, such further agreements, instruments and other
      documents, and take, or cause to be taken, such further actions, as the other
      party hereto may reasonably request as being necessary or advisable to effect
      or
      evidence the transactions contemplated by this Agreement.

     

    10. Succession
      and Assignment.
      Subject
      to the immediately following sentence, this Agreement will be binding upon
      and
      inure to the benefit of the parties hereto and their respective successors
      and
      permitted assigns, each of which such successors and permitted assigns will
      be
      deemed to be a party hereto for all purposes hereof. No party may assign,
      delegate or otherwise transfer either this Agreement or any of its rights,
      interests, or obligations hereunder without the prior written approval of the
      other party. 

     

    11. Governing
      Law.
      This
      Agreement shall be governed by and construed in accordance with the laws of
      the
      State of Delaware (without giving any effect to conflicts of laws principles
      thereof that would apply the laws of another jurisdiction).

     

    12. Amendment.
      No
      change, modification or amendment of this Agreement shall be valid or binding
      on
      the parties unless such change or modification shall be in writing signed by
      the
      party or parties against whom the same is sought to be enforced.

     

    [Remainder
      of page intentionally left blank.]

     

    
      
        
        

      

      
        6

        
          

        

      

      
        
        

      

    

    Exhibit
      10.34

    IN
      WITNESS WHEREOF, the parties hereto have caused this Contribution Agreement
      to
      be duly executed as of the date first hereinabove written.

    

      
        	
                The
                  Company:

              	Asyrmatos,
                Inc.
	 	 	 	 
	 	 	 	 
	 	 	
                By:

              	
                /s/
                  Panos Lekkas

              
	 	 	
                Name:

              	
                Panos
                  Lekkas

              
	 	 	
                Title:

              	
                Chief
                  Executive Officer

              
	 	 	 	 
	 	 	 	 
	
                The
                  Founder:

              	Lumera
                Corporation
	 	 	 	 
	 	 	 	 
	 	 	
                By:
                  

              	
                /s/
                  Peter J. Biere

              
	 	 	
                Name:

              	
                Peter
                  J. Biere

              
	 	 	
                Title:

              	
                Chief
                  Financial OfficerExhibit
      10.35

    

      INVESTORS’
        RIGHTS AGREEMENT

       

      THIS
        INVESTORS’ RIGHTS AGREEMENT
        (“Agreement”)
        is
        made as of the 20th day of February, 2008, by and among
        Asyrmatos, Inc., a Delaware corporation (the “Company”),
        and
        Lumera Corporation, a Delaware corporation (the “Investor”).

       

      RECITALS

       

      WHEREAS,
        the
        Company and the Investor are parties to the Contribution Agreement of even
        date
        herewith (the “Contribution
        Agreement”);
        and

       

      WHEREAS,
        in
        order to induce the Company to enter into the Contribution Agreement and
        to
        induce the Investor to contribute certain assets to the Company pursuant
        to the
        Contribution Agreement, the Investor and the Company hereby agree that this
        Agreement shall govern the rights of the Investor to cause the Company to
        register shares of Common Stock issuable to the Investor, to receive certain
        information from the Company, and to participate in future equity offerings
        by
        the Company, and shall govern certain other matters as set forth in this
        Agreement;

       

      NOW,
        THEREFORE,
        the
        parties hereby agree as follows:

       

      1. Definitions. For
        purposes of this Agreement:

       

      1.1 “Affiliate”
means,
        with respect to any specified Person, any other Person who or which, directly
        or
        indirectly, controls, is controlled by, or is under common control with such
        specified Person, including without limitation any general partner, officer,
        director or manager of such Person and any venture capital fund now or hereafter
        existing that is controlled by or under common control with one or more general
        partners or managing members of, or shares the same management company with,
        such Person.

       

      1.2 “Common
        Stock”
means
        shares of the Company’s common stock, par value $0.01 per share.

       

      1.3 “Class
        L Preferred Stock”
means
        shares of the Company’s Class L Preferred Stock, par value $0.01 per
        share.

       

      1.4 “Damages”
means
        any loss, damage, or liability (joint or several) to which a party hereto
        may
        become subject under the Securities Act, the Exchange Act, or other federal
        or
        state law, insofar as such loss, damage, or liability (or any action in respect
        thereof) arises out of or is based upon (i) any untrue statement or alleged
        untrue statement of a material fact contained in any registration statement
        of
        the Company, including any preliminary prospectus or final prospectus contained
        therein or any amendments or supplements thereto; (ii) an omission or
        alleged omission to state therein a material fact required to be stated therein,
        or necessary to make the statements therein not misleading; or (iii) any
        violation or alleged violation by the indemnifying party of the Securities
        Act,
        the Exchange Act, any state securities law, or any rule or regulation
        promulgated under the Securities Act, the Exchange Act, or any state securities
        law.

       

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

       

      1.5 “Derivative
        Securities”
means
        any securities or rights convertible into, or exercisable or exchangeable
        for
        (in each case, directly or indirectly), Common Stock, including options and
        warrants.

       

      1.6 “Exchange
        Act”
means
        the Securities Exchange Act of 1934, as amended, and the rules and regulations
        promulgated thereunder.

       

      1.7 “Excluded
        Registration”
means
        (i) a registration relating to the sale of securities to employees of the
        Company or a subsidiary pursuant to a stock option, stock purchase, or similar
        plan; (ii) a registration relating to an SEC Rule 145 transaction; (iii)
        a
        registration on any form that does not include substantially the same
        information as would be required to be included in a registration statement
        covering the sale of the Registrable Securities; or (iv) a registration in
        which
        the only Common Stock being registered is Common Stock issuable upon conversion
        of debt securities that are also being registered.

       

      1.8 “Form
        S-1”
means
        such form under the Securities Act as in effect on the date hereof or any
        successor registration form under the Securities Act subsequently adopted
        by the
        SEC.

       

      1.9 “Form
        S-2”
means
        such form under the Securities Act as in effect on the date hereof or any
        successor registration form under the Securities Act subsequently adopted
        by the
        SEC.

       

      1.10 “Form
        S-3”
means
        such form under the Securities Act as in effect on the date hereof or any
        registration form under the Securities Act subsequently adopted by the SEC
        that
        permits incorporation of substantial information by reference to other documents
        filed by the Company with the SEC.

       

      1.11 “GAAP”
means
        generally accepted accounting principles in the United States.

       

      1.12 “Immediate
        Family Member”
means
        a
        child,
        stepchild,
        grandchild, parent, stepparent,
        grandparent, spouse, sibling, mother-in-law, father-in-law, son-in-law,
        daughter-in-law, brother-in-law, or sister-in-law,
        including adoptive relationships, of a natural person referred to
        herein.

       

      1.13 “IPO”
means
        the Company’s first underwritten public offering of its Common Stock under the
        Securities Act.

       

      1.14 “Key
        Employee”
means
        each
        of
Panos
        Lekkas, Stanley Young, Raj Reddy and David McClain.

       

      
        
          
          

        

        
          2

          
            

          

        

        
          
          

        

      

       

      1.15 “Lumera
        Director”
means
        any director of the Company that the Investor is entitled to elect pursuant
        to
        the Company’s Certificate of Incorporation.

       

      1.16 “New
        Securities”
means,
        collectively, equity securities of the Company, whether or not currently
        authorized, as well as rights, options, or warrants to purchase such equity
        securities, or securities of any type whatsoever that are, or may become,
        convertible or exchangeable into or exercisable for such equity
        securities.

       

      1.17 “Person”
means
        any individual, corporation, partnership, trust, limited liability company,
        association or other
        entity.

       

      1.18 “Registrable
        Securities”
means
        (i) any Common Stock, or any Common Stock issued or issuable upon
        conversion and/or exercise of any other securities of the Company, acquired
        by
        the Investor on or after the date hereof; and (ii) any Common Stock issued
        as (or issuable upon the conversion or exercise of any warrant, right, or
        other
        security that is issued as) a dividend or other distribution with respect
        to, or
        in exchange for or in replacement of, the shares referenced in clause (i)
        above, excluding in all cases, however, any Registrable Securities sold by
        a
        Person in a transaction in which the applicable rights under this Agreement
        are
        not assigned pursuant to Section
        6.1,
        and
        excluding for purposes of Section
        2
        any
        shares for which registration rights have terminated pursuant to Section
        2.11
        of this
        Agreement.

       

      1.19 “Registrable
        Securities then outstanding”
means
        the number of shares determined by adding the number of shares of outstanding
        Common Stock that are Registrable Securities and the number of shares of
        Common
        Stock issuable pursuant to then exercisable and/or convertible securities
        that
        are Registrable Securities.

       

      1.20 “SEC”
means
        the Securities and Exchange Commission.

       

      1.21 “SEC
        Rule 144”
means
        Rule 144 promulgated by the SEC under the Securities Act.

       

      1.22 “SEC
        Rule 144(k)”
means
        Rule 144(k) promulgated by the SEC under the Securities Act.

       

      1.23 “SEC
        Rule 145”
means
        Rule 145 promulgated by the SEC under the Securities Act.

       

      1.24 “Securities
        Act”
means
        the Securities Act of 1933, as amended, and the rules and regulations
        promulgated thereunder.

       

      1.25 “Selling
        Expenses”
means
        all underwriting discounts, selling commissions, and stock transfer taxes
        applicable to the sale of Registrable Securities, and fees and disbursements
        of
        counsel for the Investor, except for the fees and disbursements of the Selling
        Holder Counsel borne and paid by the Company as provided in Section
        2.6.

       

      
        
          
          

        

        
          3

          
            

          

        

        
          
          

        

      

       

      2. Registration
        Rights.
        The
        Company covenants and agrees as follows:

       

      2.1 Demand
        Registration.

       

      (a) Form
        S-3 Demand.
        If at
        any time when it is eligible to use a Form S-3 registration statement, the
        Company receives a request from the Investor that the Company file a Form
        S-3
        registration statement with respect to outstanding Registrable Securities
        of the
        Investor having an anticipated aggregate offering price, net of Selling
        Expenses, of at least $1,000,000, then the Company shall, as soon as
        practicable, and in any event within sixty (60) days after the date such
        request
        is given by the Investor, file a Form S-3 registration statement under the
        Securities Act covering all Registrable Securities requested to be included
        in
        such registration by the Investor, subject to the limitations of Section
        2.1(b)
        and
Section 2.3.

       

      (b) Notwithstanding
        the foregoing obligations, if the Company furnishes to the Investor a
        certificate signed by the Company’s chief executive officer stating that in the
        good faith judgment of the Company’s Board of Directors it would be materially
        detrimental to the Company and its stockholders for such registration statement
        to either become effective or remain effective for as long as such registration
        statement otherwise would be required to remain effective, because such action
        would (i) materially interfere with a significant acquisition, corporate
        reorganization, or other similar transaction involving the Company; (ii)
        require
        premature disclosure of material information that the Company has a bona
        fide
        business purpose for preserving as confidential; or (iii) render the
        Company unable to comply with requirements under the Securities Act or Exchange
        Act, then the Company shall have the right to defer taking action with respect
        to such filing, and any time periods with respect to filing or effectiveness
        thereof shall be tolled correspondingly, for a period of not more than one
        hundred and twenty (120) days after the request of the Investor is given;
        provided,
        however,
        that
        the Company may not invoke this right more than twice in any twelve (12)
        month
        period; and provided further
        that the
        Company shall not register any securities for its own account or that of
        any
        other stockholder during such period other than an Excluded
        Registration.

       

      (c) The
        Company shall not be obligated to effect, or to take any action to effect,
        any
        registration pursuant to Section
        2.1(a)
        if (i)
        Form S-3 is not available for such offering by the Investor, (ii) during
        the
        period that is thirty (30) days before the Company’s good faith estimate of the
        date of filing of, and ending on a date that is ninety (90) days after the
        effective date of, a Company-initiated registration, provided,
        that
        the Company is actively employing in good faith commercially reasonable efforts
        to cause such registration statement to become effective; or (iii) if the
        Company has effected two registrations pursuant to Section 2.1(a)
        within
        the twelve (12) month period immediately preceding the date of such request.
        A
        registration shall not be counted as “effected” for purposes of this
Section
        2.1(c)
        until
        such time as the applicable registration statement has been declared effective
        by the SEC, unless the Investor withdraws its request for such registration,
        elect not to pay the registration expenses therefor, and
        forfeit their right to one demand registration statement pursuant
        to Section
        2.6,
        in
        which case such withdrawn registration statement shall be counted as “effected”
for purposes of this Section 2.1(c). 

       

      
        
          
          

        

        
          4

          
            

          

        

        
          
          

        

      

       

      2.2 Company
        Registration.
        If the
        Company proposes to register (including, for this purpose, a registration
        effected by the Company for stockholders other than the Investor) any of
        its
        securities under the Securities Act in connection with the public offering
        of
        such securities solely for cash (other than in an Excluded Registration),
        the
        Company shall, at such time, promptly give the Investor notice of such
        registration. Upon the request of the Investor given within twenty (20) days
        after such notice is given by the Company, the Company shall, subject to
        the
        provisions of Section
        2.3,
        cause
        to be registered all of the Registrable Securities that the Investor has
        requested to be included in such registration. The Company shall have the
        right
        to terminate or withdraw any registration initiated by it under this
Section
        2.2
        before
        the effective date of such registration, whether or not the Investor has
        elected
        to include Registrable Securities in such registration. The expenses (other
        than
        Selling Expenses) of such withdrawn registration shall be borne by the Company
        in accordance with Section
        2.6.

       

      2.3 Underwriting
        Requirements.

       

      (a) If,
        pursuant to Section
        2.1,
        the
        Investor intends to distribute the Registrable Securities covered by its
        request
        by means of an underwriting, it shall so advise the Company as a part of
        its
        request made pursuant to Section
        2.1.
        The
        underwriter(s) will be selected by the Company and shall be reasonably
        acceptable to the Investor. In such event, the right of the Investor to include
        its Registrable Securities in such registration shall be conditioned upon
        its
        participation in such underwriting and the inclusion of its Registrable
        Securities in the underwriting to the extent provided herein. The Investor
        proposing to distribute its securities through such underwriting shall (together
        with the Company as provided in Section
        2.4(e))
        enter
        into an underwriting agreement in customary form with the underwriter(s)
        selected for such underwriting. Notwithstanding any other provision of this
        Section
        2.3,
        if the
        managing underwriter(s) advise(s) the Investor in writing that marketing
        factors
        require a limitation on the number of shares to be underwritten, then the
        number
        of Registrable Securities that may be included in the underwriting shall
        be in
        proportion (as nearly as practicable) to the number of Registrable Securities
        owned by the Investor or in such other proportion as shall mutually be agreed
        to
        by the Investor; provided,
        however,
        that
        the number of Registrable Securities held by the Investor to be included
        in such
        underwriting shall not be reduced unless all other securities are first entirely
        excluded from the underwriting.

       

      (b) In
        connection with any offering involving an underwriting of shares of the
        Company’s capital stock pursuant to Section
        2.2,
        the
        Company shall not be required to include any of the Investor’s Registrable
        Securities in such underwriting unless the Investor accepts the terms of
        the
        underwriting as agreed upon between the Company and its underwriters, and
        then
        only in such quantity as the underwriters in their sole discretion determine
        will not jeopardize the success of the offering by the Company. If the total
        number of securities, including Registrable Securities, requested by
        stockholders to be included in such offering exceeds the number of securities
        to
        be sold (other than by the Company) that the underwriters in their reasonable
        discretion determine is compatible with the success of the offering, then
        the
        Company shall be required to include in the offering only that number of
        such
        securities, including Registrable Securities, which the underwriters and
        the
        Company in their sole discretion determine will not jeopardize the success
        of
        the offering. Notwithstanding the foregoing, in no event shall (i) the number
        of
        Registrable Securities included in the offering be reduced unless all other
        securities (other than securities to be sold by the Company) are first entirely
        excluded from the offering, or (ii) the number of Registrable Securities
        included in the offering be reduced below thirty percent (30%) of the total
        number of securities included in such offering, unless such offering is the
        IPO
        in which case the Investor may be excluded further if the Underwriters make
        the
        determination described above and no other stockholder's securities are included
        in such offering.

       

      
        
          
          

        

        
          5

          
            

          

        

        
          
          

        

      

       

      (c) For
        purposes of Section
        2.1,
        a
        registration shall not be counted as “effected” if, as a result of an exercise
        of the underwriter’s cutback provisions in Section
        2.3(a),
        fewer
        than fifty percent (50%) of the total number of Registrable Securities that
        the
        Investor has requested to be included in such registration statement are
        actually included.

       

      2.4 Obligations
        of the Company.
        Whenever
        required under this Section
        2
        to
        effect the registration of any Registrable Securities, the Company shall,
        as
        expeditiously as reasonably possible:

       

      (a) prepare
        and file with the SEC a registration statement with respect to such Registrable
        Securities and use its commercially reasonable efforts to cause such
        registration statement to become effective and, upon the request of the
        Investor, keep such registration statement effective for a period of up to
        one
        hundred twenty (120) days or, if earlier, until the distribution contemplated
        in
        the registration statement has been completed; provided,
        however,
        that
        (i) such one hundred twenty (120) day period shall be extended for a period
        of
        time equal to the period the Investor refrains, at the request of an underwriter
        of Common Stock (or other securities) of the Company, from selling any
        securities included in such registration, and (ii) in the case of any
        registration of Registrable Securities on Form S-3 that are intended to be
        offered on a continuous or delayed basis, subject to compliance with applicable
        SEC rules, such one hundred twenty (120) day period shall be extended for
        up to
        120 additional days, if necessary, to keep the registration statement effective
        until all such Registrable Securities are sold;

       

      (b) prepare
        and file with the SEC such amendments and supplements to such registration
        statement, and the prospectus used in connection with such registration
        statement, as may be necessary to comply with the Securities Act in order
        to
        enable the disposition of all securities covered by such registration
        statement;

       

      (c) furnish
        to the Investor such numbers of copies of a prospectus, including a preliminary
        prospectus, as required by the Securities Act, and such other documents as
        the
        Investor may reasonably request in order to facilitate the disposition of
        its
        Registrable Securities;

       

      
        
          
          

        

        
          6

          
            

          

        

        
          
          

        

      

       

      (d) use
        its
        commercially reasonable efforts to register and qualify the securities covered
        by such registration statement under such other securities or blue-sky laws
        of
        such jurisdictions as shall be reasonably requested by the Investor;
provided that
        the
        Company shall not be required to qualify to do business or to file a general
        consent to service of process in any such states or jurisdictions, unless
        the
        Company is already subject to service in such jurisdiction and except as
        may be
        required by the Securities Act;

       

      (e) in
        the
        event of any underwritten public offering, enter into and perform its
        obligations under an underwriting agreement, in usual and customary form,
        with
        the underwriter(s) of such offering;

       

      (f) use
        its
        commercially reasonable efforts to cause all such Registrable Securities
        covered
        by such registration statement to be listed on a national securities exchange
        or
        trading system and each securities exchange and trading system (if any) on
        which
        similar securities issued by the Company are then listed;

       

      (g) provide
        a
        transfer agent and registrar for all Registrable Securities registered pursuant
        to this Agreement and provide a CUSIP number for all such Registrable
        Securities, in each case not later than the effective date of such
        registration;

       

      (h) promptly
        make available for inspection by the Investor, any managing underwriter(s)
        participating in any disposition pursuant to such registration statement,
        and
        any attorney or accountant or other agent retained by any such underwriter
        or
        selected by the Investor, all financial and other records, pertinent corporate
        documents, and properties of the Company, and cause the Company’s officers,
        directors, employees, and independent accountants to supply all information
        reasonably requested by any such seller, underwriter, attorney, accountant,
        or
        agent, in each case, as necessary or advisable to verify the accuracy of
        the
        information in such registration statement and to conduct appropriate due
        diligence in connection therewith;

       

      (i) notify
        the Investor, promptly after the Company receives notice thereof, of the
        time
        when such registration statement has been declared effective or a supplement
        to
        any prospectus forming a part of such registration statement has been filed;
        and

       

      (j) after
        such registration statement becomes effective, notify the Investor of any
        request by the SEC that the Company amend or supplement such registration
        statement or prospectus.

       

      2.5 Furnish
        Information.
        It
        shall be a condition precedent to the obligations of the Company to take
        any
        action pursuant to this Section
        2
        with
        respect to the Registrable Securities of the Investor that it shall furnish
        to
        the Company such information regarding itself, the Registrable Securities
        held
        by it, and the intended method of disposition of such securities as is
        reasonably required to effect the registration of its Registrable
        Securities.

       

      
        
          
          

        

        
          7

          
            

          

        

        
          
          

        

      

       

      2.6 Expenses
        of Registration.
        All
        expenses (other than Selling Expenses) incurred in connection with
        registrations, filings, or qualifications pursuant to Section 2,
        including all registration, filing, and qualification fees; printers’ and
        accounting fees; fees and disbursements of counsel for the Company; and the
        reasonable fees and disbursements, not to exceed $5,000 of one counsel for
        the
        Investor, shall be borne and paid by the Company; provided,
        however,
        that
        the Company shall not be required to pay for any expenses of any registration
        proceeding begun pursuant to Section
        2.1
        if the
        registration request is subsequently withdrawn at the request of the Investor,
        unless the Investor agrees to forfeit its right to one registration pursuant
        to
Section
        2.1(a),
        as the
        case may be; provided further
        that if,
        at the time of such withdrawal, the Investor has learned of a material adverse
        change in the condition or business of the Company from that known to the
        Investor at the time of its request and has withdrawn the request with
        reasonable promptness after learning of such information, then the Investor
        shall not be required to pay any of such expenses and will not forfeit its
        right
        to one registration pursuant to Section
        2.1(a).
        All
        Selling Expenses relating to Registrable Securities registered pursuant to
        this
Section 2
        shall be
        borne and paid by the Investor.

       

      2.7 Indemnification.
        If any
        Registrable Securities are included in a registration statement under this
        Section
        2:

       

      (a) To
        the
        extent permitted by law, the Company will indemnify and hold harmless the
        Investor, and the partners, members, officers, directors, and stockholders
        of
        the Investor; legal counsel and accountants for the Investor; any underwriter
        (as defined in the Securities Act) for the Investor; and each Person, if
        any,
        who controls the Investor or underwriter within the meaning of the Securities
        Act or the Exchange Act, against any Damages, and the Company will pay to
        the
        Investor, underwriter, controlling Person, or other aforementioned Person
        any
        legal or other expenses reasonably incurred thereby in connection with
        investigating any matter or defending any proceeding from which Damages may
        result, as such expenses are incurred; provided,
        however,
        that
        the indemnity agreement contained in this Section
        2.8(a)
        shall
        not apply to amounts paid in settlement of any such investigation or proceeding
        if such settlement is effected without the consent of the Company, which
        consent
        shall not be unreasonably withheld, nor shall the Company be liable for any
        Damages to the extent that they arise out of or are based upon actions or
        omissions made in reliance upon and in conformity with written information
        furnished by or on behalf of the Investor, underwriter, controlling Person,
        or
        other aforementioned Person expressly for use in connection with such
        registration.

       

      (b) To
        the
        extent permitted by law, the Investor will indemnify and hold harmless the
        Company, and each of its directors, each of its officers who has signed the
        registration statement, each Person (if any), who controls the Company within
        the meaning of the Securities Act, legal counsel and accountants for the
        Company, any underwriter (as defined in the Securities Act), the Investor
        and
        any controlling Person of any such underwriter, against any Damages, in each
        case only to the extent that such Damages arise out of or are based upon
        actions
        or omissions made in reliance upon and in conformity with written information
        furnished by or on behalf of the Investor expressly for use in connection
        with
        such registration; and the Investor will pay to the Company and each other
        aforementioned Person any legal or other expenses reasonably incurred thereby
        in
        connection with investigating any investigation or defending any proceeding
        from
        which Damages may result, as such expenses are incurred; provided,
        however,
        that
        the indemnity agreement contained in this Section
        2.8(b)
        shall
        not apply to amounts paid in settlement of any such investigation or proceeding
        if such settlement is effected without the consent of the Investor, which
        consent shall not be unreasonably withheld; and provided
        further
        that in
        no event shall any indemnity under this Section
        2.8(b)
        exceed
        the proceeds from the offering received by the Investor (net of any Selling
        Expenses paid by the Investor), except in the case of fraud or willful
        misconduct by the Investor.

       

      
        
          
          

        

        
          8

          
            

          

        

        
          
          

        

      

       

      (c) Promptly
        after receipt by an indemnified party under this Section 2.8
        of
        notice of the commencement of any action (including any governmental action)
        for
        which a party may be entitled to indemnification hereunder, such indemnified
        party will, if a claim in respect thereof is to be made against any indemnifying
        party under this Section
        2.8,
        give
        the indemnifying party notice of the commencement thereof. The indemnifying
        party shall have the right to participate in such action and, to the extent
        the
        indemnifying party so desires, participate jointly with any other indemnifying
        party to which notice has been given, and to assume the defense thereof with
        counsel mutually satisfactory to the parties; provided,
        however,
        that an
        indemnified party (together with all other indemnified parties that may be
        represented without conflict by one counsel) shall have the right to retain
        one
        separate counsel, with the fees and expenses to be paid by the indemnifying
        party, if representation of such indemnified party by the counsel retained
        by
        the indemnifying party would be inappropriate due to actual or potential
        differing interests between such indemnified party and any other party
        represented by such counsel in such action. The failure to give notice to
        the
        indemnifying party within a reasonable time of the commencement of any such
        action shall relieve such indemnifying party of any liability to the indemnified
        party under this Section
        2.8,
        to the
        extent that such failure materially prejudices the indemnifying party’s ability
        to defend such action. The failure to give notice to the indemnifying party
        will
        not relieve it of any liability that it may have to any indemnified party
        otherwise than under this Section
        2.8.

       

      (d) Notwithstanding
        anything else herein to the contrary, the foregoing indemnity agreements
        of the
        Company and the Investor are subject to the condition that, insofar as they
        relate to any Damages arising from any untrue statement or alleged untrue
        statement of a material fact contained in, or omission or alleged omission
        of a
        material fact from, a preliminary prospectus (or necessary to make the
        statements therein not misleading) that has been corrected in the form of
        prospectus included in the registration statement at the time it becomes
        effective, or any amendment or supplement thereto filed with the SEC pursuant
        to
        Rule 424(b) under the Securities Act (the “Final
        Prospectus”),
        such
        indemnity agreement shall not inure to the benefit of any Person if a copy
        of
        the Final Prospectus was furnished to the indemnified party and such indemnified
        party failed to deliver, at or before the confirmation of the sale of the
        shares
        registered in such offering, a copy of the Final Prospectus to the Person
        asserting the loss, liability, claim, or damage in any case in which such
        delivery was required by the Securities Act.

       

      
        
          
          

        

        
          9

          
            

          

        

        
          
          

        

      

       

      (e) To
        provide for just and equitable contribution to joint liability under the
        Securities Act in any case in which either (i) any party otherwise entitled
        to
        indemnification hereunder makes a claim for indemnification pursuant to this
        Section
        2.8
        but it
        is judicially determined (by the entry of a final judgment or decree by a
        court
        of competent jurisdiction and the expiration of time to appeal or the denial
        of
        the last right of appeal) that such indemnification may not be enforced in
        such
        case, notwithstanding the fact that this Section
        2.8
        provides
        for indemnification in such case, or (ii) contribution under the Securities
        Act
        may be required on the part of any party hereto for which indemnification
        is
        provided under this Section 2.8,
        then,
        and in each such case, such parties will contribute to the aggregate losses,
        claims, damages, liabilities, or expenses to which they may be subject (after
        contribution from others) in such proportion as is appropriate to reflect
        the
        relative fault of each of the indemnifying party and the indemnified party
        in
        connection with the statements, omissions, or other actions that resulted
        in
        such loss, claim, damage, liability, or expense, as well as to reflect any
        other
        relevant equitable considerations. The relative fault of the indemnifying
        party
        and of the indemnified party shall be determined by reference to, among other
        things, whether the untrue or allegedly untrue statement of a material fact,
        or
        the omission or alleged omission of a material fact, relates to information
        supplied by the indemnifying party or by the indemnified party and the parties’
relative intent, knowledge, access to information, and opportunity to correct
        or
        prevent such statement or omission; provided,
        however,
        that,
        in any such case, (x) the Investor will not be required to contribute any
        amount in excess of the public offering price of all such Registrable Securities
        offered and sold by the Investor pursuant to such registration statement,
        and
        (y) no Person guilty of fraudulent misrepresentation (within the meaning
        of
        section 11(f) of the Securities Act) will be entitled to contribution from
        any
        Person who was not guilty of such fraudulent misrepresentation; and provided further
        that in
        no event shall the Investor’s liability pursuant to this Section
        2.8(e),
        when
        combined with the amounts paid or payable by the Investor pursuant to
Section
        2.8(b),
        exceed
        the proceeds from the offering received by the Investor (net of any Selling
        Expenses), except in the case of willful misconduct or fraud by the
        Investor.

       

      (f) Notwithstanding
        the foregoing, to the extent that the provisions on indemnification and
        contribution contained in the underwriting agreement entered into in connection
        with the underwritten public offering are in conflict with the foregoing
        provisions, the provisions in the underwriting agreement shall
        control.

       

      (g) Unless
        otherwise superseded by an underwriting agreement entered into in connection
        with the underwritten public offering, the obligations of the Company and
        the
        Investor under this Section
        2.8
        shall
        survive the completion of any offering of Registrable Securities in a
        registration under this Section
        2,
        and
        otherwise shall survive the termination of this Agreement. 

       

      
        
          
          

        

        
          10

          
            

          

        

        
          
          

        

      

       

      2.8 Reports
        Under Exchange Act.
        With a
        view to making available to the Investor the benefits of SEC Rule 144 and
        any
        other rule or regulation of the SEC that may at any time permit the Investor
        to
        sell securities of the Company to the public without registration or pursuant
        to
        a registration on Form S-3, the Company shall:

       

      (a) make
        and
        keep available adequate public information, as those terms are understood
        and
        defined in SEC Rule 144, at all times after the effective date of the
        registration statement filed by the Company for the IPO;

       

      (b) use
        commercially reasonable efforts to file with the SEC in a timely manner all
        reports and other documents required of the Company under the Securities
        Act and
        the Exchange Act (at any time after the Company has become subject to such
        reporting requirements); and

       

      (c) furnish
        to the Investor, so long as the Investor owns any Registrable Securities,
        forthwith upon request (i) to the extent accurate, a written statement by
        the
        Company that it has complied with the reporting requirements of SEC Rule
        144 (at
        any time after ninety (90) days after the effective date of the registration
        statement filed by the Company for the IPO), the Securities Act, and the
        Exchange Act (at any time after the Company has become subject to such reporting
        requirements), or that it qualifies as a registrant whose securities may
        be
        resold pursuant to Form S-3 (at any time after the Company so qualifies);
        (ii) a
        copy of the most recent annual or quarterly report of the Company and such
        other
        reports and documents so filed by the Company; and (iii) such other information
        as may be reasonably requested in availing the Investor of any rule or
        regulation of the SEC that permits the selling of any such securities without
        registration (at any time after the Company has become subject to the reporting
        requirements under the Exchange Act) or pursuant to Form S-3 (at any time
        after
        the Company so qualifies to use such form).

       

      2.9 Limitations
        on Subsequent Registration Rights.
        From and
        after the date of this Agreement, the Company shall not, without the prior
        written consent of the Investor, enter into any agreement with any holder
        or
        prospective holder of any securities of the Company that would allow such
        holder
        or prospective holder (i) to include such securities in any registration
        unless,
        under the terms of such agreement, such holder or prospective holder may
        include
        such securities in any such registration only to the extent that the inclusion
        of such securities will not reduce the number of the Registrable Securities
        of
        the Investor that are included or (ii) to demand registration of any securities
        held by the Investor..

       

      2.10 “Market
        Stand-off” Agreement.
        The
        Investor hereby agrees that it will not, without the prior written consent
        of
        the managing underwriter, during the period commencing on the date of the
        final
        prospectus relating to the IPO and ending on the date specified by the Company
        and the managing underwriter (such period not to exceed one hundred eighty
        (180)
        days, which period may be extended upon the request of the managing underwriter
        for an additional period of up to fifteen (15) days if the Company issues
        or
        proposes to issue an earnings or other public release within fifteen (15)
        days
        of the expiration of the 180-day lockup period), (i) lend; offer; pledge;
        sell;
        contract to sell; sell any option or contract to purchase; purchase any option
        or contract to sell; grant any option, right, or warrant to purchase; or
        otherwise transfer or dispose of, directly or indirectly, any shares of Common
        Stock or any securities convertible into or exercisable or exchangeable for
        Common Stock held immediately before
        the effective date of the registration statement for such offering or
        (ii) enter into any swap or other arrangement that transfers to another, in
        whole or in part, any of the economic consequences of ownership of such
        securities, whether any such transaction described in clause (i) or (ii)
        above
        is to be settled by delivery of Common Stock or other securities, in cash,
        or
        otherwise. The foregoing provisions of this Section
        2.10
        shall
        apply only to the IPO, shall not apply to the sale of any shares to an
        underwriter pursuant to an underwriting agreement, and shall be applicable
        to
        the Investor only if all officers, directors, and stockholders individually
        owning more than one percent (1%) of the Company’s outstanding Common Stock
        (after giving effect to conversion into Common Stock of all outstanding Class
        L
        Preferred Stock) are subject to the same restrictions. The underwriters in
        connection with the IPO are intended third-party beneficiaries of this
Section
        2.10
        and
        shall have the right, power, and authority to enforce the provisions hereof
        as
        though they were a party hereto. The Investor further agrees to execute such
        agreements as may be reasonably requested by the underwriters in connection
        with
        the IPO that are consistent with this Section
        2.10
        or that
        are necessary to give further effect thereto. Any discretionary waiver or
        termination of the restrictions of any or all of such agreements by the Company
        or the underwriters shall apply to the Investor to the extent that it is
        subject
        to such agreements.

       

      
        
          
          

        

        
          11

          
            

          

        

        
          
          

        

      

       

      2.11 Termination
        of Registration Rights. The
        right
        of the Investor to request registration or inclusion of Registrable Securities
        in any registration pursuant to Section
        2.1
        or
Section
        2.2
        shall
        terminate upon the earliest to occur of:

       

      (a) the
        closing of a Deemed Liquidation Event, as such term is defined in the Company’s
        Certificate of Incorporation; or

       

      (b) when
        all
        of the Investor’s Registrable Securities could be sold without restriction under
        SEC Rule 144(k) within any 90 days period.

       

      3. Information
        Rights.

       

      3.1 Delivery
        of Financial Statements.  The
        Company shall deliver to the Investor:

       

      (a) as
        soon
        as practicable, but in any event within ninety (90) days after the end of
        each
        fiscal year of the Company, (i) a balance sheet as of the end of such year,
        (ii)
        statements of income and of cash flows for such year, and (iii) a statement
        of
        stockholders’ equity as of the end of such year; 

       

      (b) as
        soon
        as practicable, but in any event within forty-five (45) days after the end
        of
        each of the first three (3) quarters of each fiscal year of the Company,
        unaudited statements of income and of cash flows for such fiscal quarter,
        and an
        unaudited balance sheet and a statement of stockholders’ equity as of the end of
        such fiscal quarter,
        all
        prepared in accordance with GAAP (except that such financial statements may
        (i)
        be subject to normal year-end audit adjustments and (ii) not contain all
        notes
        thereto that may be required in accordance with GAAP);

       

      
        
          
          

        

        
          12

          
            

          

        

        
          
          

        

      

       

      (c) as
        soon
        as practicable, but in any event thirty (30) days before the end of each
        fiscal
        year, a budget and business plan for the next fiscal year (collectively,
        the
“Budget”),
        approved by the Board of Directors and prepared on a monthly basis, including
        balance sheets, income statements, and statements of cash flow for such months
        and, promptly after prepared, any other budgets or revised budgets prepared
        by
        the Company;

       

      (d) such
        other information relating to the financial condition, business, prospects,
        or
        corporate affairs of the Company as the Investor may from time to time
        reasonably request; provided,
        however,
        that
        the Company shall not be obligated under this Section
        3.1
        to
        provide information (i) that the Company reasonably determines in good faith
        to
        be a trade secret or confidential information (unless covered by an enforceable
        confidentiality agreement, in form acceptable to the Company) or (ii) the
        disclosure of which would adversely affect the attorney-client privilege
        between
        the Company and its counsel. 

       

      If,
        for
        any period, the Company has any subsidiary whose accounts are consolidated
        with
        those of the Company, then in respect of such period the financial statements
        delivered pursuant to the foregoing sections shall be the consolidated and
        consolidating financial statements of the Company and all such consolidated
        subsidiaries.

       

      Notwithstanding
        anything else in this Section 3.1 to the contrary, the Company may cease
        providing the information set forth in this Section 3.1 during the period
        starting with the date sixty (60) days before the Company’s good-faith estimate
        of the date of filing of a registration statement; provided that the Company’s
        covenants under this Section 3.1 shall be reinstated at such time as the
        Company
        is no longer actively employing its commercially reasonable efforts to cause
        such registration statement to become effective.

       

      3.2 Inspection.
        The
        Company shall permit the Investor, at the Investor’s expense, to visit and
        inspect the Company’s properties; examine its books of account and records; and
        discuss the Company’s affairs, finances, and accounts with its officers, during
        normal business hours of the Company as may be reasonably requested by the
        Investor; provided,
        however,
        that
        the Company shall not be obligated pursuant to this Section
        3.2
        to
        provide access to any information that it reasonably considers to be a trade
        secret or confidential information (unless covered by an enforceable
        confidentiality agreement, in form acceptable to the Company) or the disclosure
        of which would adversely affect the attorney-client privilege between the
        Company and its counsel. 

       

      3.3 Termination
        of Information Rights.
        The
        covenants set forth in Section
        3.1
        and
Section
        3.2
        shall
        terminate and be of no further force or effect (i) immediately before the
        consummation of the IPO, or (ii) when the Company first becomes subject to
        the periodic reporting requirements of section 12(g) or 15(d) of the Exchange
        Act, or (iii) upon a Deemed Liquidation Event, as such term is defined in
        the
        Company’s Certificate of Incorporation, whichever event occurs
        first. 

       

      
        
          
          

        

        
          13

          
            

          

        

        
          
          

        

      

       

      3.4 Confidentiality.
        The
        Investor will keep confidential and will not disclose, divulge, or use for
        any
        purpose (other than to monitor its investment in the Company) any
        confidential information obtained from the Company pursuant to the terms
        of this
        Agreement (including notice of the Company’s intention to file a registration
        statement), unless such confidential information (a) is known or becomes
        known
        to the
        public in general (other than as a result of a breach of this Section
        3.4
        by the
        Investor), (b) is or has been independently developed or conceived by the
        Investor without use of the Company’s confidential information, or (c) is or has
        been made known or disclosed to the Investor by a third party without a breach
        of any obligation of confidentiality such third party may have to the Company;
        provided,
        however,
        that
        the Investor may disclose confidential information (i) to its attorneys,
        accountants, consultants, and other professionals to the extent necessary
        to
        obtain their services in connection with monitoring its investment in the
        Company; (ii) to any prospective purchaser of any Registrable Securities
        from
        the Investor, if such prospective purchaser agrees to be bound by the provisions
        of this Section
        3.4;
        (iii)
        to any existing or prospective Affiliate, partner, member, stockholder, or
        wholly owned subsidiary of the Investor in the ordinary course of business,
        provided that
        the
        Investor informs such Person that such information is confidential and directs
        such Person to maintain the confidentiality of such information;
        or (iv)
        as may otherwise be required by law, provided that
        the
        Investor promptly notifies the Company of such disclosure and takes reasonable
        steps to minimize the extent of any such required disclosure. 

       

      4. Rights
        to Future Stock Issuances.

       

      4.1 Right
        of First Offer.
        Subject
        to the terms and conditions of this Section
        4.1
        and
        applicable securities laws, if the Company proposes to offer or sell any
        New
        Securities, the Company shall first offer such New Securities to the Investor.
        The Investor shall be entitled to apportion the right of first offer hereby
        granted to it among itself and its Affiliates in such proportions as it deems
        appropriate.

       

      (a) The
        Company shall give notice (the “Offer
        Notice”)
        to the
        Investor, stating (i) its bona fide intention to offer such New Securities,
        (ii) the number of such New Securities to be offered, and (iii) the price
        and
        terms, if any, upon which it proposes to offer such New Securities.

       

      (b) By
        notification to the Company within twenty (20) days after the Offer Notice
        is
        given, the Investor may elect to purchase or otherwise acquire, at the price
        and
        on the terms specified in the Offer Notice, up to that portion of such New
        Securities which equals the proportion that the Common Stock issued and held,
        or
        issuable (directly or indirectly) upon conversion and/or exercise, as
        applicable, of the Class L Preferred Stock and any other Derivative Securities
        then held, by the Investor bears to the total Common Stock of the Company
        then
        outstanding (assuming full conversion and/or exercise, as applicable, of
        all
        Class L Preferred Stock and other Derivative Securities). The closing of
        any
        sale pursuant to this Section 4.1(b) shall occur within the later of one
        hundred twenty (120) days of the date that the Offer Notice is given and
        the
        date of initial sale of New Securities pursuant to Section
        4.1(c).

       

      
        
          
          

        

        
          14

          
            

          

        

        
          
          

        

      

       

      (c) If
        all
        New Securities referred to in the Offer Notice are not elected to be purchased
        or acquired as provided in Section
        4.1(b),
        the
        Company may, during the ninety (90) day period following the expiration of
        the
        periods provided in Section
        4.1(b),
        offer
        and sell the remaining unsubscribed portion of such New Securities to any
        Person
        or Persons at a price not less than, and upon terms no more favorable to
        the
        offeree than, those specified in the Offer Notice. If the Company does not
        enter
        into an agreement for the sale of the New Securities within such period,
        or if
        such agreement is not consummated within thirty (30) days of the execution
        thereof, the right provided hereunder shall be deemed to be revived and such
        New
        Securities shall not be offered unless first reoffered to the Investor in
        accordance with this Section
        4.1.

       

      (d) The
        right
        of first offer in this Section
        4.1
        shall
        not be applicable to (i) Exempted Securities (as defined in the Company’s
        Certificate of Incorporation); and (ii) shares of Common Stock issued in
        the IPO.

       

      4.2 Termination.
        The
        covenants set forth in Section
        4.1
        shall
        terminate and be of no further force or effect (i) immediately before the
        consummation of the IPO, (ii) when the Company first becomes subject to the
        periodic reporting requirements of section 12(g) or 15(d) of the Exchange
        Act,
        or (iii) upon a Deemed Liquidation Event, as such term is defined in the
        Company’s Certificate of Incorporation, whichever event occurs
        first.

       

      5. Additional
        Covenants.

       

      5.1 Employee
        Agreements.
        The
        Company will cause (i) each person now or hereafter employed by it or by
        any
        subsidiary (or engaged by the Company or any subsidiary as a
        consultant/independent contractor) with access to confidential information
        and/or trade secrets to enter into a nondisclosure and proprietary rights
        assignment agreement and (ii) each Key Employee to enter into a one (1) year
        non-competition and non-solicitation agreement, substantially in the form
        approved by the Board of Directors. In addition, the Company shall not amend,
        modify, terminate, waive, or otherwise alter, in whole or in part, any of
        the
        above-referenced agreements or any restricted stock agreement between the
        Company and any employee, without the consent of the member of the Board
        of
        Directors elected by the Investor.

       

      5.2 Employee
        Vesting.
        Unless
        otherwise approved by the Board of Directors, all future employees and
        consultants of the Company who purchase, receive options to purchase, or
        receive
        awards of shares of the Company’s capital stock after the date hereof shall be
        required to execute restricted stock or option agreements, as applicable,
        providing for (i) vesting of shares over a four (4) year period, with the
        first twenty-five percent (25%) of such shares vesting following one (1)
        year
        of
        continued employment or service, and the remaining shares vesting in equal
        monthly installments over the following three (3) years, and (ii) a market
        stand-off provision substantially similar to that in Section
        2.11.
        In
        addition, unless otherwise approved by the Board of Directors, the Company
        shall
        retain a “right of first refusal” on employee transfers until the Company’s IPO
        and shall have the right to repurchase unvested shares at cost upon termination
        of employment of a holder of restricted stock.

       

      
        
          
          

        

        
          15

          
            

          

        

        
          
          

        

      

       

      5.3 Matters
        Requiring Investor Director Approval. So long as the Investor is entitled to
        elect a member of the Board of Directors, the Company hereby covenants and
        agrees with the Investor that it shall not, without approval of the Board
        of
        Directors, which approval must include the affirmative vote of the Lumera
        Director:

       

      (a) make,
        or
        permit any subsidiary to make, any loan or advance to, or own any stock or
        other
        securities of, any subsidiary or other corporation, partnership, or other
        entity
        unless it is wholly owned by the Company;

       

      (b) make,
        or
        permit any subsidiary to make, any loan or advance to any Person, including,
        without limitation, any employee or director of the Company or any subsidiary,
        except advances and similar expenditures in the ordinary course of business
        or
        under the terms of an employee stock or option plan approved by the Board
        of
        Directors;

       

      (c) guarantee,
        directly or indirectly, or permit any subsidiary to guarantee, directly or
        indirectly, any indebtedness except for trade accounts of the Company or
        any
        subsidiary arising in the ordinary course of business; 

       

      (d) make
        any
        investment inconsistent with the Lumera Corporation investment policy, which
        is
        attached hereto as Exhibit
        A;
        

       

      (e) incur
        any
        aggregate indebtedness in excess of $25,000 that is not already included
        in a
        budget approved by the Board of Directors (including the approval of the
        Class L
        Director), other than trade credit incurred in the ordinary course of business;
        

       

      (f) otherwise
        enter into or be a party to any transaction with any director, officer, or
        employee of the Company or any “associate” (as defined in Rule 12b-2 promulgated
        under the Exchange Act) of any such Person, except for transactions contemplated
        by this Agreement or the Purchase Agreement; 

       

      (g) change
        the principal business of the Company, enter new lines of business, exit
        the
        current line of business or acquire (by purchase of assets, stock or otherwise)
        another business or entity; or

       

      (h) sell,
        assign, license, pledge, or encumber material technology or intellectual
        property, other than licenses granted in the ordinary course of
        business.

       

      5.4 Meetings
        of the Board of Directors.
        Unless
        otherwise determined by the vote of a majority of the directors then in office,
        the Board of Directors shall meet at least quarterly, in accordance with
        an
        agreed-upon schedule. 

       

      
        
          
          

        

        
          16

          
            

          

        

        
          
          

        

      

       

      5.5 Successor
        Indemnification.
        If
        the
        Company or any of its successors or assignees (i) consolidates with or merges
        into any other Person and is not the continuing or surviving corporation
        or
        entity of such consolidation or merger or (ii) transfers or conveys all or
        substantially all of its properties and assets to any Person, then, and in
        each
        such case, to the extent necessary, proper provision shall be made so that
        the
        successors and assignees of the Company assume the obligations of the Company
        with respect to indemnification of members of the Board of Directors as in
        effect immediately before such transaction, whether such obligations are
        contained in the Company’s Bylaws, its Certificate of Incorporation, or
        elsewhere, as the case may be.

       

      5.6 Committees
        of the Board.
        If the
        Board establishes any Board committees, the Lumera Director shall have the
        right
        to serve on each such committee.

       

      5.7 Board
        Expenses.
        The
        Company shall reimburse the non-employee directors for all reasonable
        out-of-pocket travel expenses incurred (consistent with the Company’s travel
        policy) in connection with attending meetings of the Board of
        Directors.

       

      5.8 Call
        Right.
        The
        Company agrees that all of the Common and Preferred Stock of the Company
        which
        has been issued and will be issued shall be subject to the right of the Investor
        to purchase all of the issued and outstanding Common and Preferred Stock
        not
        then held by it (the "Call Right") upon the fourth anniversary of the date
        of
        this Agreement (the "Call Date"). Such right shall be exercised, if at all,
        by
        delivery of a written notice of exercise to the President of the Company
        within
        sixty (60) days of the Call Date. The Call Right may only be exercised as
        to all
        of the Common and Preferred Stock outstanding as of the Call Date and no
        partial
        exercise of the Call Right shall be permitted. Upon the exercise of the Call
        Right, the Investor shall be entitled to purchase all of the outstanding
        Common
        and Preferred Stock of the Company, as of the Call Date, at its fair market
        value, as determined by an independent appraiser that is mutually satisfactory
        to the Company and the Investor. As part of such valuation, the appraiser
        shall
        not take into account discounts for the lack of marketability of the stock
        or
        the lack of a controlling stock interest in the Corporation which collectively
        exceed 20%. The Call Right shall expire, if the Investor fails to exercise
        the
        Call Right at the time and in the manner set forth herein.

       

      5.9 Termination
        of Covenants.
        The
        covenants set forth in this Section
        5,
        except
        for Section
        5.5,
        shall
        terminate and be of no further force or effect (i) immediately before the
        consummation of the IPO, (ii) when the Company first becomes subject to the
        periodic reporting requirements of section 12(g) or 15(d) of the Exchange
        Act,
        or (iii) upon a Deemed Liquidation Event, as such term is defined in the
        Company’s Certificate of Incorporation, whichever event occurs first.
        

       

      6. Miscellaneous.

       

      6.1 Successors
        and Assigns.
        The
        rights under this Agreement may be assigned (but only with all related
        obligations) by the Investor to a transferee of Registrable Securities
that
        (i)
        is an Affiliate, partner, member, limited partner, retired partner, retired
        member, or stockholder of the Investor; (ii) after
        such transfer, holds at least one hundred thousand (100,000) shares of
        Registrable Securities (subject to appropriate adjustment for stock splits,
        stock dividends, combinations, and other recapitalizations); provided,
        however,
        that
        (x) the Company is, within a reasonable time after such transfer, furnished
        with
        written notice of the name and address of such transferee and the Registrable
        Securities with respect to which such rights are being transferred; and
        (y) such transferee agrees in a written instrument delivered to the Company
        to be bound by and subject to the terms and conditions of this Agreement,
        including the provisions of Section
        2.11.
        For the
        purposes of determining the number of shares of Registrable Securities held
        by a
        transferee, the holdings of a
        transferee that
        is
        an Affiliate, limited partner, retired partner, member, retired member, or
        stockholder of the
        Investor
        shall be
        aggregated together and with those of the transferring Holder; provided further
        that all
        transferees who would not qualify individually for assignment of registration
        rights shall have a single attorney-in-fact for the purpose of exercising
        any
        rights, receiving notices, or taking any action under this Agreement. The
        terms
        and conditions of this Agreement inure to the benefit of and are binding
        upon
        the respective successors and permitted assignees of the parties. Nothing
        in
        this Agreement, express or implied, is intended to confer upon any party
        other
        than the parties hereto or their respective successors and permitted assignees
        any rights, remedies, obligations or liabilities under or by reason of this
        Agreement, except as expressly provided herein.
        Notwithstanding the foregoing, any transferee of Common Stock or Preferred
        Stock
        shall be subject to the obligations of this Agreement, including the obligations
        of Section 2.11.

       

      
        
          
          

        

        
          17

          
            

          

        

        
          
          

        

      

       

      6.2 Governing
        Law;
        Jurisdiction.
        This
        Agreement shall be governed by and construed in accordance with the General
        Corporation Law of the State of Delaware as to matters within the scope thereof,
        and as to all other matters shall be governed by and construed in accordance
        with the internal laws of the State of Delaware, without regard to its
        principles of conflicts of laws. The
        parties (a) hereby irrevocably and unconditionally submit to the jurisdiction
        of
        the state and federal courts located in the State of Delaware for the purpose
        of
        any suit, action or other proceeding arising out of or based upon this Agreement
        (“Covered
        Matters”),
        (b)
        agree not to commence any suit, action or other proceeding arising out of
        or
        based upon any Covered Matters except in the state courts or federal courts
        located in the State of Delaware, and (c) hereby waive, and agree not to
        assert,
        by way of motion, as a defense, or otherwise, in any such suit, action or
        proceeding, any claim that it is not subject personally to the jurisdiction
        of
        the above-named courts, that its property is exempt or immune from attachment
        or
        execution, that the suit, action or proceeding is brought in an inconvenient
        forum, that the venue of the suit, action or proceeding is improper or that
        this
        Agreement or the subject matter of any Covered Matter may not be enforced
        in or
        by such court.

       

      6.3 Counterparts;
        Facsimile.
        This
        Agreement may also be executed and delivered by facsimile signature and in
        two
        or more counterparts, each of which shall be deemed an original, but all
        of
        which together shall constitute one and the same instrument.

       

      6.4 Titles
        and Subtitles.
        The
        titles and subtitles used in this Agreement are for convenience only and
        are not
        to be considered in construing or interpreting this Agreement.

       

      6.5 Notices.
        All
        notices, requests, and other communications given or made pursuant to this
        Agreement shall be in writing and shall be deemed effectively given, delivered
        and received (i) upon personal delivery to the party to be notified; (ii)
        when
        sent by confirmed electronic mail or facsimile if sent during normal business
        hours of the recipient, and if not so confirmed, then on the next business
        day;
        (iii) five (5) days after having been sent by registered or certified mail,
        return receipt requested, postage prepaid; or (iv) one (1) business day after
        the business day of deposit with a nationally recognized overnight courier,
        specifying next-day delivery, with written verification of receipt. All
        communications shall be sent to the respective parties at their addresses
        as set
        forth on Schedule
        A
        hereto,
        or to the principal office of the Company and to the attention of the Chief
        Executive Officer, in the case of the Company, or to such email address,
        facsimile number, or address as subsequently modified by written notice given
        in
        accordance with this Section
        6.5.
        If
        notice is given to the Investor, a copy shall also be sent to Christopher
        Austin
        at Ropes & Gray LLP, One Embarcadero Center Suite 2200, San Francisco, CA
        94111.

       

      
        
          
          

        

        
          18

          
            

          

        

        
          
          

        

      

       

      6.6 Amendments
        and Waivers.
        Any term
        of this Agreement may be amended and the observance of any term of this
        Agreement may be waived (either generally or in a particular instance, and
        either retroactively or prospectively) only with the written consent of the
        Company and the Investor; provided,
        that
        any
        provision hereof may be waived by any waiving party on such party’s own behalf,
        without the consent of any other party. No waivers of or exceptions to any
        term,
        condition, or provision of this Agreement, in any one or more instances,
        shall
        be deemed to be or construed as a further or continuing waiver of any such
        term,
        condition, or provision.

       

      6.7 Severability.
        In case
        any one or more of the provisions contained in this Agreement is for any
        reason
        held to be invalid, illegal or unenforceable in any respect, such invalidity,
        illegality, or unenforceability shall not affect any other provision of this
        Agreement, and such invalid, illegal, or unenforceable provision shall be
        reformed and construed so that it will be valid, legal, and enforceable to
        the
        maximum extent permitted by law.

       

      6.8 Aggregation
        of Stock.
        All
        shares of Registrable Securities held or acquired by Affiliates shall be
        aggregated together for the purpose of determining the availability of any
        rights under this Agreement.

       

      6.9 Entire
        Agreement.
        This
        Agreement (including any Schedules and Exhibits hereto), the Restricted
        Certificate and the other Transaction Documents (as defined in the Purchase
        Agreement) constitutes the full and entire understanding and agreement among
        the
        parties with respect to the subject matter hereof, and any other written
        or oral
        agreement relating to the subject matter hereof existing between the parties
        is
        expressly canceled. 

       

      6.10 Delays
        or Omissions.
        No
        delay or omission to exercise any right, power, or remedy accruing to any
        party
        under this Agreement, upon any breach or default of any other party under
        this
        Agreement, shall impair any such right, power, or remedy of such nonbreaching
        or
        non-defaulting party, nor shall it be construed to be a waiver of or
        acquiescence to any such breach or default, or to any similar breach or default
        thereafter occurring, nor shall any waiver of any single breach or default
        be
        deemed a waiver of any other breach or default theretofore or thereafter
        occurring. Any waiver, permit, consent or approval of any kind or character
        on
        the part of any party of any breach or default under this Agreement, or any
        waiver on the part of any party of any provisions or conditions of this
        Agreement, must be in writing and shall be effective only to the extent
        specifically set forth in such writing. All remedies, whether under this
        Agreement or by law or otherwise afforded to any party, shall be cumulative
        and
        not alternative.

       

      6.11 Further
        Assurances.
        At any
        time or from time to time after the date hereof, the parties agree to cooperate
        with each other, and at the request of any other party, to execute and deliver
        any further instruments or documents and to take all such further action
        as the
        other party may reasonably request in order to evidence or effectuate the
        consummation of the transactions contemplated hereby and to otherwise carry
        out
        the intent of the parties hereunder.

       

      [Remainder
        of Page Intentionally Left Blank]

       

      
        
          
          

        

        
          19

          
            

          

        

        
          
          

        

      

      IN
        WITNESS WHEREOF, the parties have executed this Agreement as of the date
        first
        written above.

       

      
        
          	 	 
	
                  ASYRMATOS,
                    INC.

                
	 	 
	 	 
	
                  By:

                	
                  /s/
                    Panos Lekkas

                
	
                  Name:

                	
                  Panos
                    Lekkas

                
	
                  Title:

                	
                  Chief
                    Executive Officer

                
	 	 
	 	 
	 	 
	
                  LUMERA
                    CORPORATION

                
	 	 
	 	 
	
                  By:

                	
                  /s/
                    Peter J. Biere

                
	
                  Name:

                	
                  Peter
                    J. Biere

                
	
                  Title:

                	
                  Chief
                    Financial Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00139-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00139-of-00352.parquet"}]]